Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanpu Ji

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Internal Medicine (Tokyo, Japan)|November 20, 2010
Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infectionFanpu Ji, Zhengxiao Li, Heng Ge, et al.
The Journal of Infectious Diseases|August 11, 2020
Reply to Rabelo-da-Ponte et alQing-Lei Zeng, Zu-Jiang Yu, Fanpu Ji
Alimentary Pharmacology & Therapeutics|October 9, 2019
Letter: hepatocellular carcinoma negatively affects sustained virological response of direct-acting anti-viral treatment in decompensated cirrhosisCaini He, Shen Li, Yunyu Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2024
Re-Assessing the Non-Linear Trends in the Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease From 1990 to 2021Fang Lu, Bingyang She, Fanpu Ji, et al.
Journal of Hepatology|February 12, 2013
Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: further evidence in decompensation cirrhosisFanpu Ji, Shu Zhang, Hong Deng, et al.
The Journal of Infectious Diseases|May 31, 2020
Response to MalkovskyQing-Lei Zeng, Fanpu Ji, Ji-Yuan Zhang
Journal of Hepatology|March 30, 2022
Reply to: "Gut liver muscle brain axis: A comprehensive viewpoint on prognosis in cirrhosis"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Journal of Hepatology|May 3, 2022
Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Stem Cells Translational Medicine|April 23, 2020
Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019Fanpu Ji, Liya Li, Zongfang Li, et al.
Global Health Research and Policy|May 20, 2025
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021Jinli Liu, Tingling Xu, Yanan Wang, et al.
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Internal Medicine (Tokyo, Japan)|November 20, 2010
Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infectionFanpu Ji, Zhengxiao Li, Heng Ge, et al.
The Journal of Infectious Diseases|August 11, 2020
Reply to Rabelo-da-Ponte et alQing-Lei Zeng, Zu-Jiang Yu, Fanpu Ji
Alimentary Pharmacology & Therapeutics|October 9, 2019
Letter: hepatocellular carcinoma negatively affects sustained virological response of direct-acting anti-viral treatment in decompensated cirrhosisCaini He, Shen Li, Yunyu Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2024
Re-Assessing the Non-Linear Trends in the Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease From 1990 to 2021Fang Lu, Bingyang She, Fanpu Ji, et al.
Journal of Hepatology|February 12, 2013
Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: further evidence in decompensation cirrhosisFanpu Ji, Shu Zhang, Hong Deng, et al.
The Journal of Infectious Diseases|May 31, 2020
Response to MalkovskyQing-Lei Zeng, Fanpu Ji, Ji-Yuan Zhang
Journal of Hepatology|March 30, 2022
Reply to: "Gut liver muscle brain axis: A comprehensive viewpoint on prognosis in cirrhosis"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Journal of Hepatology|May 3, 2022
Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Stem Cells Translational Medicine|April 23, 2020
Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019Fanpu Ji, Liya Li, Zongfang Li, et al.
Global Health Research and Policy|May 20, 2025
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021Jinli Liu, Tingling Xu, Yanan Wang, et al.
Pageof 15